News & Events
Crinetics Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics granted non-qualified stock option awards to purchase an aggregate of 258,800 shares of its common stock to twenty-seven new non-executive employees.
READ MORECrinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
Crinetics announces the pricing of an upsized underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $50. 00 per share
READ MORECrinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
Crinetics announces that it intends to offer and sell, subject to market and other conditions, $400. 0 million of shares of its common stock in a proposed underwritten public offering.
READ MORECrinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
Crinetics announces the submission of a New Drug Application to the FDA for its investigational drug, paltusotine, for the treatment of acromegaly.
READ MORECrinetics Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics granted non-qualified stock option awards to purchase an aggregate of 120,000 shares of its common stock to fifteen new non-executive employees.
READ MORECrinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences
Crinetics management will participate in fireside chats at the Morgan Stanley 22nd Annual Global Healthcare Conference and the Cantor Global Healthcare Conference.
READ MORECrinetics Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics granted non-qualified stock option awards to purchase an aggregate of 103,900 shares of its common stock to fifteen new non-executive employees.
READ MORETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
